Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho-proliferative disorders: a single centre experience
2009 ◽
Vol 45
(3)
◽
pp. 534-542
◽
2020 ◽
Vol 39
(4)
◽
pp. S501
2014 ◽
Vol 20
(2)
◽
pp. S222-S223
◽
2007 ◽
Vol 40
(4)
◽
pp. 369-372
◽
2009 ◽
Vol 15
(2)
◽
pp. 131
2012 ◽
Vol 91
(7)
◽
pp. 1081-1089
◽
2004 ◽
Vol 35
(2)
◽
pp. 165-169
◽